医学
置信区间
入射(几何)
儿科
急诊医学
内科学
药物不良反应
药物反应
药品
药理学
光学
物理
作者
Jason Lazarou,Bruce Pomeranz,Paul Corey
出处
期刊:JAMA
[American Medical Association]
日期:1998-04-15
卷期号:279 (15): 1200-1200
被引量:4408
标识
DOI:10.1001/jama.279.15.1200
摘要
To estimate the incidence of serious and fatal adverse drug reactions (ADR) in hospital patients.Four electronic databases were searched from 1966 to 1996.Of 153, we selected 39 prospective studies from US hospitals.Data extracted independently by 2 investigators were analyzed by a random-effects model. To obtain the overall incidence of ADRs in hospitalized patients, we combined the incidence of ADRs occurring while in the hospital plus the incidence of ADRs causing admission to hospital. We excluded errors in drug administration, noncompliance, overdose, drug abuse, therapeutic failures, and possible ADRs. Serious ADRs were defined as those that required hospitalization, were permanently disabling, or resulted in death.The overall incidence of serious ADRs was 6.7% (95% confidence interval [CI], 5.2%-8.2%) and of fatal ADRs was 0.32% (95% CI, 0.23%-0.41%) of hospitalized patients. We estimated that in 1994 overall 2216000 (1721000-2711000) hospitalized patients had serious ADRs and 106000 (76000-137000) had fatal ADRs, making these reactions between the fourth and sixth leading cause of death.The incidence of serious and fatal ADRs in US hospitals was found to be extremely high. While our results must be viewed with circumspection because of heterogeneity among studies and small biases in the samples, these data nevertheless suggest that ADRs represent an important clinical issue.
科研通智能强力驱动
Strongly Powered by AbleSci AI